Seqens Seqens

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Digital content for Vivera Pharmaceuticals

    Client Virtual Booth

    VIVERA PHARMACEUTICALS

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass
    Contact SupplierContact Supplier
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Send me more info on How To Grow My Bussiness Digitally?
    Vivera Pharmaceuticals
    United_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    4533 MacArthur Blvd 5049 Newport Beach, California 92660
    Telephone
    Telephone
    1.844.484.8372
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://viverapharmaceuticals.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/viverapharmaceuticals
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Full View ScreenFull Screen View
    Vivera Prevails in Litigation Against Former Commissioner Pedram Salimpour
    Vivera Prevails in Litigation Against Former Commissioner Pedram Salimpour

    https://www.accesswire.com/viewarticle.aspx?id=796157&lang=en

    ACCESSWIRE
    26 Oct 2023
    Share Share
    Vivera Welcomes Former FDA Investigator Dennis Moore as Regulatory Advisor
    Vivera Welcomes Former FDA Investigator Dennis Moore as Regulatory Advisor

    https://www.prnewswire.com/news-releases/vivera-welcomes-former-fda-investigator-dennis-moore-as-regulatory-and-compliance-advisor-301746304.html

    PR NEWSWIRE
    14 Feb 2023
    Share Share
    Vivera Expands TABMELT Global Licensing Reach with Grant of Israel Patent
    Vivera Expands TABMELT Global Licensing Reach with Grant of Israel Patent

    https://www.prnewswire.com/news-releases/vivera-expands-tabmelt-global-licensing-reach-with-grant-of-israel-patent-301714172.html

    PR NEWSWIRE
    05 Jan 2023
    Share Share
    Vivera Welcomes Publicist Amanda Whitcroft as Director of Public Relations
    Vivera Welcomes Publicist Amanda Whitcroft as Director of Public Relations

    https://www.prnewswire.com/news-releases/vivera-welcomes-seasoned-publicist-amanda-whitcroft-as-director-of-public-relations-301696691.html

    PRNEWSWIRE
    07 Dec 2022
    Share Share
    Vivera’s Tabmelt platform receives Israel patent
    Vivera’s Tabmelt platform receives Israel patent

    http://pharmabiz.com/NewsDetails.aspx?aid=154106&sid=2

    PHARMABIZ
    29 Oct 2022
    Share Share
    Vivera Enters $6B Market with Feedback Device Patent Allowance
    Vivera Enters $6B Market with Feedback Device Patent Allowance

    https://www.prnewswire.com/news-releases/vivera-enters-6b-market-with-speech-assessment-and-feedback-device-patent-allowance-301658035.html

    PRNEWSWIRE
    25 Oct 2022
    Share Share
    Vivera Welcomes Healthcare Founder and CEO Lea Ramirez to its Advisory Board
    Vivera Welcomes Healthcare Founder and CEO Lea Ramirez to its Advisory Board

    https://www.prnewswire.com/news-releases/vivera-welcomes-healthcare-founder-and-ceo-lea-ramirez-to-its-advisory-board-301654360.html

    PRNEWSWIRE
    20 Oct 2022
    Share Share
    Vivera Appoints Regulatory Leader Dr. Geetha Rao to Advisory Board
    Vivera Appoints Regulatory Leader Dr. Geetha Rao to Advisory Board

    https://www.prnewswire.com/news-releases/vivera-appoints-world-renowned-regulatory-leader-dr-geetha-rao-to-advisory-board-301647844.html

    PRNEWSWIRE
    12 Oct 2022
    Share Share
    Sublingual delivery firm hits back against SEC fraud complaint
    Sublingual delivery firm hits back against SEC fraud complaint

    https://www.fiercepharma.com/pharma/politically-motivated-sublingual-delivery-firm-hits-back-against-sec-fraud-complaint

    Nick Paul Taylor FIERCEPHARMA
    04 Oct 2022
    Share Share
    Vivera Files Response Defending Against The SEC's Recent Threat Of A Civil Suit
    Vivera Files Response Defending Against The SEC's Recent Threat Of A Civil Suit

    https://www.prnewswire.com/news-releases/vivera-files-response-defending-itself-against-the-secs-recent-threat-of-a-civil-suit-301638303.html

    PRNEWSWIRE
    30 Sep 2022
    Share Share
    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    veranova-m-2024-04-22

    Access Virtual Booth

    Contact Supplier

    Send me more info on How To Grow My Business Digitally?
    Post Enquiry
    POST ENQUIRY

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search